Literature DB >> 12851649

Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking.

Gerd Müller1, Martin Lipp.   

Abstract

The effective onset of adaptive immune responses requires that naïve antigen-specific lymphocytes, being inherently rare throughout the body, rapidly encounter foreign antigens. This problem has been elegantly solved in evolution by inventing secondary lymphoid tissues as intersections in the migratory pathway of antigen-presenting dendritic cells and antigen-specific lymphocytes. Chemokines play a central role in guiding cell movements in the course of immune responses and in lymphoid system homeostasis. In particular, the chemokine receptors CCR7 and CXCR5 are key molecules for the entry of lymphocytes and dendritic cells into secondary lymphoid organs and their homing to T-cell and B-cell zones therein. CCR7 and CXCR5 are differentially expressed on the cell surface of lymphocytes and dendritic cells depending on the stage of cellular differentiation and activation, thus allowing these cells to change their homing capacity and prospective traffic routes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12851649     DOI: 10.1038/sj.mn.7800197

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  16 in total

1.  Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy.

Authors:  Juhua Zhou; Mark E Dudley; Steven A Rosenberg; Paul F Robbins
Journal:  J Immunother       Date:  2005 Jan-Feb       Impact factor: 4.456

2.  Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas.

Authors:  Shaomei Cheng; Jingyan Guo; Qing Yang; Xiangshan Yang
Journal:  Med Oncol       Date:  2015-01-31       Impact factor: 3.064

3.  Human Innate Immune Cells Respond Differentially to Poly-γ-Glutamic Acid Polymers from Bacillus anthracis and Nonpathogenic Bacillus Species.

Authors:  Tanya M Jelacic; Wilson J Ribot; Jennifer Chua; Anne E Boyer; Adrian R Woolfitt; John R Barr; Arthur M Friedlander
Journal:  J Immunol       Date:  2020-01-13       Impact factor: 5.422

Review 4.  Lymphoid chemokines in the CNS.

Authors:  Stephen J Lalor; Benjamin M Segal
Journal:  J Neuroimmunol       Date:  2010-06-01       Impact factor: 3.478

5.  Exposure to Bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cells.

Authors:  Tanya M Jelacic; Donald J Chabot; Joel A Bozue; Steven A Tobery; Michael W West; Krishna Moody; De Yang; Joost J Oppenheim; Arthur M Friedlander
Journal:  Infect Immun       Date:  2014-06-02       Impact factor: 3.441

6.  Janus kinase 3-deficient T lymphocytes have an intrinsic defect in CCR7-mediated homing to peripheral lymphoid organs.

Authors:  Eduardo A García-Zepeda; Ileana Licona-Limón; M Fernanda Jiménez-Sólomon; Gloria Soldevila
Journal:  Immunology       Date:  2007-05-22       Impact factor: 7.397

7.  Young T Cells Age During a Redirected Anti-Tumor Attack: Chimeric Antigen Receptor-Provided Dual Costimulation is Half the Battle.

Authors:  Andreas A Hombach; Hinrich Abken
Journal:  Front Immunol       Date:  2013-06-05       Impact factor: 7.561

8.  Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5.

Authors:  Caroline Schmutz; Alison Hulme; Angela Burman; Mike Salmon; Brian Ashton; Christopher Buckley; Jim Middleton
Journal:  Arthritis Res Ther       Date:  2004-12-16       Impact factor: 5.156

Review 9.  Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets.

Authors:  Jens Geginat; Giulia Nizzoli; Moira Paroni; Stefano Maglie; Paola Larghi; Steve Pascolo; Sergio Abrignani
Journal:  Front Immunol       Date:  2015-10-13       Impact factor: 7.561

Review 10.  Inflammatory Alteration of Human T Cells Exposed Continuously to Asbestos.

Authors:  Naoko Kumagai-Takei; Shoko Yamamoto; Suni Lee; Megumi Maeda; Hidenori Masuzzaki; Nagisa Sada; Min Yu; Kei Yoshitome; Yasumitsu Nishimura; Takemi Otsuki
Journal:  Int J Mol Sci       Date:  2018-02-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.